Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1981
Mode of action of the heme-controlled translational inhibitor: relationship of eukaryotic initiation factor 2-stimulating protein to translation restoring factorJ Siekierka, K I Mitsui, S Ochoa
Infection and Immunity|May 1, 1984
Mode of inhibitory action of a bacteriocin produced by Streptococcus mutans C3603K Takada, T Ikeda, I Mitsui, et al.
Journal of Biochemistry|February 1, 1983
Investigation of actin in Tetrahymena cells. A comparison with skeletal muscle actin by a devised two-dimensional gel electrophoresis methodT Hirabayashi, R Tamura, I Mitsui, et al.
Journal of Comparative Pathology|June 8, 2020
Amyloid Signature Proteins in Feline AmyloidosisS Miyazaki, A Kadota, I Mitsui, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assayK Inoue, T Mukaiyama, I Mitsui, et al.
Neurologia Medico-Chirurgica|February 1, 1995
Lumbar adhesive arachnoiditis following attempted epidural anesthesia--case reportT Haisa, T Todo, I Mitsui, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|September 1, 1996
[Interstitial pneumonia complicated by rapidly progressive glomerulonephritis associated with anti-myeloperoxydase antibody]I Mitsui, H Ichihara, K Kusajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1985
[Enhanced cytotoxic effect of Adriamycin and vincristine against PC-6 (human lung cancer cell line) and Hattori (human breast cancer cell line)]M Terashima, K Inoue, T Mukaiyama, et al.
European Journal of Biochemistry|November 1, 1996
Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin O), a cholesterol-binding cytolysinN Sekino-Suzuki, M Nakamura, K I Mitsui, et al.
International Journal of Cancer|August 7, 1997
DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variantN Joto, M Ishii, M Minami, et al.
Pageof 3